Abstract:(1) Background: Gene editing technology, as represented by CRISPR is a powerful tool used in biomedical science. However, the editing efficiency of such technologies, especially in induced pluripotent stem cells (iPSCs) and other types of stem cells, is low which hinders its application in regenerative medicine; (2) Methods: A gene-editing system, COE, was designed and constructed based on CRISPR/Cas12a and Orip/EBNA1, and its editing efficiency was evaluated in human embryonic kidney 293T (HEK-293T) cells with flow cytometry and restriction fragment length polymorphism (RFLP) analysis. The COE was nucleofected into iPSCs, then, the editing efficiency was verified by a polymerase chain reaction and Sanger sequencing; (3) Results: With the extension of time, COE enables the generation of up to 90% insertion or deletion rates in HEK-293T cells. Furthermore, the deletion of a 2.5 kb fragment containing Exon 51 of the dystrophin gene (DMD) in iPSCs was achieved with high efficiency; out of 14 clones analyzed, 3 were positive. Additionally, the Exon 51-deleted iPSCs derived from cardiomyocytes had similar expression profiles to those of Duchenne muscular dystrophy (DMD) patient-specific iPSCs. Moreover, there was no residue of each component of the plasmid in the editing cells; (4) Conclusions: In this study, a novel, efficient, and safe gene-editing system, COE, was developed, providing a powerful tool for gene editing.

Derivation of Induced Pluripotent Stem Cells Line (RCPCMi009-A-1) with Knockout of the UBE2A Gene by CRISPR/Cas9 Genome Editing

Derivation of Induced Pluripotent Stem Cells Line (RCPCMi009-A-1) with Knockout of the UBE2A Gene Using CRISPR/Cas9 Genome Editing

Generation of a Lamin A/C Knockout Human Induced Pluripotent Stem Cell Line (Zjulli007-A) Via CRISPR/Cas9

CRISPR/Cas9 Mediated Generation of a Ipsc Line EHTJUi005-A-1 with Homozygous Knockout of the SUV39H1 Gene.

An Episomal CRISPR/Cas12a System for Mediating Efficient Gene Editing

Generation of an NCS1 gene knockout human induced pluripotent stem cell line using CRISPR/Cas9

Generation of an NANS Homozygous Knockout Human Induced Pluripotent Stem Cell Line by the Insertion of GFP-P2A-Puro Via CRISPR/Cas9 Editing.

Generation of human induced pluripotent stem cell lines from a subject with UBAP1L-associated retinal dystrophy and CRISPR/cas9-corrected isogenic iPSC lines

Generation of a KCNJ11 Homozygous Knockout Human Embryonic Stem Cell Line WAe001-A-12 Using CRISPR/Cas9.

Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins.

Generation of Induced Pluripotent Stem Cell Line iTAF15Xsk4 from Fibroblasts of a Patient with Microdeletion at Xq24

Generation of a laminopathies-specific iPSC line EHTJUi005-A-3 with homozygous knockout of the <i>LMNA</i> gene by CRISPR/Cas9 technology

Generation of a NONO homozygous knockout human induced pluripotent stem cell line by CRISPR/Cas9 editing.

Generation of NERCe003-A-3, a P53 Compound Heterozygous Mutation Human Embryonic Stem Cell Line, by CRISPR/Cas9 Editing.

Engineering Human Stem Cell Lines with Inducible Gene Knockout Using CRISPR/Cas9

Generation of a TMEM43 knockout human induced pluripotent stem cell line (HDZi003-A-1) using CRISPR/Cas9

Efficient Generation and Correction of Mutations in Human iPS Cells Utilizing mRNAs of CRISPR Base Editors and Prime Editors

Generation of Human Embryonic Stem Cell Line with Heterozygous RB1 Deletion by CRIPSR/Cas9 Nickase.

Generation of a Homozygous HDAC6 Knockout Human Embryonic Stem Cell Line by CRISPR/Cas9 Editing.

Generation of Human Isogenic Induced Pluripotent Stem Cell Lines with CRISPR Prime Editing

Generation of homozygous and heterozygous REEP1 knockout induced pluripotent stem cell lines by CRISPR/Cas9 gene editing